Prognostic factors and survival study in high-grade glioma in a hospital in Lima, Peru

Factores pronóstico de supervivencia en adultos por gliomas de alto grado en un hospital de Lima, Perú

Authors

DOI:

https://doi.org/10.25176/RFMH.v20i3.3170

Keywords:

Survival, Progression-free survival, Karnofsky performance status, Glioma

Abstract

Introduction: Gliomas are primary tumors of the central nervous system. They are classifiedfrom grade I-IV, with high grade III and IV being the most frequent and with poor prognosis. Objective: To determine the prognostic factors of survival in patients with high-gradegliomas in a hospital in Lima, Peru. Methods: The medical records with high-grade gliomafrom 2010-2014 were retrospectively reviewed, ten variables were analyzed with Kaplan-Meier and Log Rank survival graphs and the Cox regression model. Results: Out of a total of278 patients with high-grade gliomas, 136 were men and 142 women. The analysis of Progression-Free Survival (SLP) had a range of 5.6-80.3 (median 22.7) and the analysis ofoverall survival (PS) had a range of 4-83.2 (median 26, 2 months. The overall survival for theIV grade tumor was 15.7 months (95% CI 14.2-17.1); the III degree was 38.4 months (95%CI 35.8-40.9). The grade (PS: HR 15; SLP: HR 25.1); surgical treatment (PS: HR 0.6; SLP:HR 0.49), age (PS: HR 1.47; SLP: HR 1.7), adjuvant treatment (PS: HR 0.6; SLP: HR 0 , 58)and karnofsky (PS: HR 0.7) were correlated; while the Karnofsky for SLP does not (P =0.146). Conclusion: age, functional status, surgical treatment, adjuvant treatment, and tumorgrade are prognostic factors for PS. In contrast, for SLP the prognostic factors were age,surgical treatment, adjuvant treatment, and tumor grade.

Downloads

Download data is not yet available.

Published

2020-07-22

How to Cite

Méndez-Aguilar, P., & Vera-Ponce, V. J. (2020). Prognostic factors and survival study in high-grade glioma in a hospital in Lima, Peru: Factores pronóstico de supervivencia en adultos por gliomas de alto grado en un hospital de Lima, Perú. Revista De La Facultad De Medicina Humana, 20(3), 12. https://doi.org/10.25176/RFMH.v20i3.3170